Search for new Alzheimer's drugs is costly, risky

09/6/2013 | NBC News

Analysts estimate that treatment for Alzheimer's could generate sales of at least $20 billion, but the development process carries uncertainty and a high price. The Pharmaceutical Research and Manufacturers of America has said more than 80 drugs are in development, but most have not reached late-stage trials. There is concern that drugmakers may reduce investments in Alzheimer's drug research if the next round of late-stage studies is not promising, Bertha Coombs writes.

View Full Article in:

NBC News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT